PlainPharmaWatch

CMS Open Payments · Tool

Electromed, Inc. vs Purdue Pharmaceuticals L.P.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Purdue Pharmaceuticals L.P. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 6,374, versus 130 for the other company. Its single largest recorded recipient represents 0.8% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Electromed, Inc.
HHI 130 · top recipient 0.1%
Ranked #1,644 of 1,838 companies by HHI
Purdue Pharmaceuticals L.P.
HHI 6,374 · top recipient 0.8%
Ranked #251 of 1,838 companies by HHI

Payment Overview

Company A

Electromed, Inc.

Total Payments
$249.6K
% of Industry
0.0%
Transactions
11,742
Avg per Transaction
$21.26
Recipients
11,742
Avg per Recipient
$21.26
Payment Types
2
Top Payment Type
Food and Beverage
Total Payments
$248.5K
% of Industry
0.0%
Transactions
50
Avg per Transaction
$5.0K
Recipients
50
Avg per Recipient
$5.0K
Payment Types
1
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Electromed, Inc. vs Purdue Pharmaceuticals L.P. - total reported payments in CMS Open Payments PY2024

Electromed, Inc.$249.6KPurdue Pharmaceuticals L.P.$248.5K

Payment Types Breakdown

Electromed, Inc.

Food and Beverage $166.1K

66.5%

Consulting Fee $83.5K

33.5%

Purdue Pharmaceuticals L.P.

Consulting Fee $248.5K

100.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Electromed, Inc.

  1. 1

    Ut Health Center At Tyler

    $23,305.00 · 2 txns

  2. 2

    Temple University Hospital

    $7,879.58 · 2 txns

  3. 3

    Emory University Hospital

    $7,800.00 · 1 txns

  4. 4

    Allegheny General Hospital

    $5,500.00 · 1 txns

  5. 5

    Uc Davis Medical Center

    $4,000.00 · 1 txns

Purdue Pharmaceuticals L.P.

  1. 1

    LESLIE BYRNE

    $194,495.30 · 25 txns

  2. 2

    JOLENE S SPENCER

    $33,588.00 · 12 txns

  3. 3

    MARGIE SANDER

    $20,132.04 · 12 txns

  4. 4

    KAREN ELLEN BOHLEN

    $289.90 · 1 txns

Summary Comparison

Metric Electromed, Inc. Purdue Pharmaceuticals L.P.
Total Payments $249.6K $248.5K
% of Industry Total 0.0% 0.0%
Transaction Count 11,742 50
Avg per Transaction $21.26 $5.0K
Recipient Count 11,742 50
Avg per Recipient $21.26 $5.0K
Payment Type Count 2 1
Top Payment Type Food and Beverage Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.